Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 8—August 2024
Dispatch
ST913-IVa-t991 Methicillin-Resistant Staphylococcus aureus among Pediatric Patients, Israel
Moti Baum
, Einav Anuka, Maya Davidovich-Cohen, and Assaf Rokney
, Einav Anuka, Maya Davidovich-Cohen, and Assaf Rokney
Figure 3
Figure 3. Percentage of resistant isolates to antibacterial agents tested among 116 t991 MRSA isolates from Israel tested for antimicrobial susceptibility using the broth microdilution method. MRSA, methicillin-resistant Staphylococcus aureus.
Page created: July 10, 2024
Page updated: July 16, 2024
Page reviewed: July 16, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.